According to Marinus Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $30.98 M. In 2022 the company made a revenue of $25.47 M an increase over the years 2021 revenue that were of $15.34 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $30.98 M | 21.63% |
2022 | $25.47 M | 66.03% |
2021 | $15.34 M | 793.19% |
2020 | $1.71 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Supernus Pharmaceuticals
SUPN | $0.60 B | 1,860.44% | ๐บ๐ธ USA |
Endo International
ENDPQ | $2.01 B | 6,391.07% | ๐ฎ๐ช Ireland |
AcelRx Pharmaceuticals
ACRX | $0.65 M | -97.90% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | $0.25 B | 731.10% | ๐บ๐ธ USA |